Metaraminol Bitartrate
CAS:33402-03-8
Molecular Formula:C13H19NO8
A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
We specialize in R & D and manufacturing, and wholesale high-quality products. We have the perfect after-sales service and technical support. Look forward to your cooperation!
CAS:33402-03-8
Molecular Formula:C13H19NO8
A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
CAS: 186826-86-8
Chemical Properties :Light yellow to yellow crystalline powder
Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis.
CAS Number: 59-26-7
Nicosamide is a kind of respiratory stimulant commonly used in clinical practice. It has a relatively large safety range and a short maintenance time in the body. After administration, it is better to administer a small amount, intermittently, and alternately.
CAS:6192-52-5
Appearance and properties: white crystal
It is a strong organic acid used as an organic catalyst in organic synthesis.
Uses: Organic synthesis, determination of primary amines, dye industry.
CAS:97281-48-6
application:
Hydrogenated L-α-phosphatidylcholine (soy) can be used to generate liposomes to rebuild the complement-active human plasma, bupivacaine and dexamethasone load.
DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9.IC50 value: 15 nM [1]Target: DPP4 inhibitorDBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated. DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetesmellitus.
CAS Number: 26351-19-9
Molecular Formula: C4H5N3O5
Molecular Weight: 175.100
All information we received Will be used in accordance with our Privacy Policy